Klarić, K.; Šribar, A.; Budisavljević, A.; Labinac, L.; Valković Zujić, P. Evaluation of Contrast-enhanced Mammography and Development of Flowchart for BI-RADS Classification of Breast Lesions. Diagnostics2023, 13, 1958.
Klarić, K.; Šribar, A.; Budisavljević, A.; Labinac, L.; Valković Zujić, P. Evaluation of Contrast-enhanced Mammography and Development of Flowchart for BI-RADS Classification of Breast Lesions. Diagnostics 2023, 13, 1958.
Klarić, K.; Šribar, A.; Budisavljević, A.; Labinac, L.; Valković Zujić, P. Evaluation of Contrast-enhanced Mammography and Development of Flowchart for BI-RADS Classification of Breast Lesions. Diagnostics2023, 13, 1958.
Klarić, K.; Šribar, A.; Budisavljević, A.; Labinac, L.; Valković Zujić, P. Evaluation of Contrast-enhanced Mammography and Development of Flowchart for BI-RADS Classification of Breast Lesions. Diagnostics 2023, 13, 1958.
Abstract
This study aimed to evaluate contrast-enhanced mammography (CEM) and compare breast lesions on CEM and breast magnetic resonance imaging (MRI) using 5 features. We propose to create a flowchart for BI-RADS classification of breast lesions on CEM based on the Kaiser score (KS) flowchart for breast MRI. Included were 68 subjects (women and men; median age 61.4 ± 11.6 years) who were suspected of having a malignant process in the breast based on digital mammography (MG) findings. The patients underwent breast ultrasound (US), CEM, MRI, and biopsy of the suspicious lesion. There were 47 patients with malignant lesions confirmed by biopsy and 21 patients with benign lesions, for each of which a KS was calculated. In the patients with malignant lesions, the MRI-derived KS was 9 (IQR 8-9), its CEM equivalent was 9 (IQR 8-9), and BI-RADS was 5 (IQR 4-5). In patients with benign lesions, MRI-derived KS was 3 (IQR 2-3), its CEM equivalent was 3 (IQR 1.7-5), and BI-RADS was 3 (IQR 0-4). There was no significant difference between the ROC-AUC of CEM and MRI (P=0.749). In conclusion, there were no significant differences in KS results between CEM and breast MRI. The KS flowchart is useful for evaluating breast lesions on CEM.
Keywords
breast cancer; contrast-enhanced mammography; magnetic resonance imaging
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
